Literature DB >> 21355843

A combination of two antioxidants (an SOD mimic and ascorbate) produces a pro-oxidative effect forcing Escherichia coli to adapt via induction of oxyR regulon.

Ines Batinic-Haberle1, Zrinka Rajic, Ludmil Benov.   

Abstract

Cationic Mn(III) N-alkylpyridyl (MnTalkyl-2(or 3)-PyP(5+)) and N, N'-dialkylimidazolylporphyrins (MnTDalkyl-2-ImP(5+)) have been regarded as the most powerful SOD mimics/peroxynitrite scavengers - i. e. antioxidants. The ethyl-, MnTE-2-PyP(5+) (AEOL10113), and hexylpyridyl-, MnTnHex-2-PyP(5+) and diethylimidazolylporphyrin, MnTDE-2-ImP(5+) (AEOL10150) have been mostly studied in vitro and in vivo. Given the in vivo abundance of cellular reductants, MnPs can couple with them in removing superoxide. Thus, they could be readily reduced from Mn(III)P to Mn(II)P with ascorbate and glutathione, and in a subsequent step reduce either O(2)(.-) (while acting as superoxide reductase) or oxygen (while exerting pro-oxidative action). Moreover, MnPs can catalyze ascorbate oxidation and in turn hydrogen peroxide production. The in vivo type of MnP action (anti- or pro-oxidative) will depend upon the cellular levels of reactive species, endogenous antioxidants, availability of oxygen, ratio of O(2)(.-)- to peroxide-removing systems, redox ability of MnPs and their cellular localization/bioavailibility. To exemplify the switch from an anti- to pro-oxidative action we have explored a very simple and straightforward system - the superoxide-specific aerobic growth of SOD-deficient E. coli. In such a system, cationic MnPs, ortho and meta MnTE-2-(or 3)-PyP(5+) act as powerful SOD mimics. Yet, in the presence of exogenous ascorbate, the SOD mimics catalyze the H(2)O(2) production, causing oxidative damage to both wild and SOD-deficient strains and inhibiting their growth. Catalase added to the medium reversed the effect indicating that H(2)O(2) is a major damaging/signaling species involved in cell growth suppression. The experiments with oxyR- and soxRS-deficient E. coli were conducted to show that E. coli responds to increased oxidative stress exerted by MnP/ascorbate system by induction of oxyR regulon and thus upregulation of antioxidative defenses such as catalases and peroxidases. As anticipated, when catalase was added into medium to remove H(2)O(2), E. coli did not respond with upregulation of its own antioxidant systems.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21355843      PMCID: PMC3652549          DOI: 10.2174/187152011795677562

Source DB:  PubMed          Journal:  Anticancer Agents Med Chem        ISSN: 1871-5206            Impact factor:   2.505


  101 in total

1.  Low molecular weight catalytic metalloporphyrin antioxidant AEOL 10150 protects lungs from fractionated radiation.

Authors:  Zahid N Rabbani; Fawzia K Salahuddin; Pavel Yarmolenko; Ines Batinic-Haberle; Bradley A Thrasher; Benjamin Gauter-Fleckenstein; Mark W Dewhirst; Mitchell S Anscher; Zeljko Vujaskovic
Journal:  Free Radic Res       Date:  2007-11

Review 2.  Targeting lipophilic cations to mitochondria.

Authors:  Michael P Murphy
Journal:  Biochim Biophys Acta       Date:  2008-04-08

3.  Impact of electrostatics in redox modulation of oxidative stress by Mn porphyrins: protection of SOD-deficient Escherichia coli via alternative mechanism where Mn porphyrin acts as a Mn carrier.

Authors:  Júlio S Rebouças; Gilson DeFreitas-Silva; Ivan Spasojević; Ynara M Idemori; Ludmil Benov; Ines Batinić-Haberle
Journal:  Free Radic Biol Med       Date:  2008-05-05       Impact factor: 7.376

4.  Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice.

Authors:  Qi Chen; Michael Graham Espey; Andrew Y Sun; Chaya Pooput; Kenneth L Kirk; Murali C Krishna; Deena Beneda Khosh; Jeanne Drisko; Mark Levine
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-04       Impact factor: 11.205

5.  ZEB1 expression in type I vs type II endometrial cancers: a marker of aggressive disease.

Authors:  Meenakshi Singh; Nicole S Spoelstra; Annie Jean; Erin Howe; Kathleen C Torkko; Hilda R Clark; Douglas S Darling; Kenneth R Shroyer; Kathryn B Horwitz; Russell R Broaddus; Jennifer K Richer
Journal:  Mod Pathol       Date:  2008-05-16       Impact factor: 7.842

Review 6.  Cellular defenses against superoxide and hydrogen peroxide.

Authors:  James A Imlay
Journal:  Annu Rev Biochem       Date:  2008       Impact factor: 23.643

Review 7.  The controversial place of vitamin C in cancer treatment.

Authors:  J Verrax; P Buc Calderon
Journal:  Biochem Pharmacol       Date:  2008-09-30       Impact factor: 5.858

Review 8.  High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer.

Authors:  Satoshi Ohno; Yumiko Ohno; Nobutaka Suzuki; Gen-Ichiro Soma; Masaki Inoue
Journal:  Anticancer Res       Date:  2009-03       Impact factor: 2.480

Review 9.  Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2.

Authors:  Fiona E Harrison; James M May
Journal:  Free Radic Biol Med       Date:  2009-01-06       Impact factor: 7.376

10.  Dysfunction of Nrf-2 in CF epithelia leads to excess intracellular H2O2 and inflammatory cytokine production.

Authors:  Junnan Chen; Michael Kinter; Samuel Shank; Calvin Cotton; Thomas J Kelley; Assem G Ziady
Journal:  PLoS One       Date:  2008-10-10       Impact factor: 3.240

View more
  18 in total

1.  Manganoporphyrins and ascorbate enhance gemcitabine cytotoxicity in pancreatic cancer.

Authors:  John A Cieslak; Robert K Strother; Malvika Rawal; Juan Du; Claire M Doskey; Samuel R Schroeder; Anna Button; Brett A Wagner; Garry R Buettner; Joseph J Cullen
Journal:  Free Radic Biol Med       Date:  2015-02-26       Impact factor: 7.376

Review 2.  Diverse functions of cationic Mn(III) N-substituted pyridylporphyrins, recognized as SOD mimics.

Authors:  Ines Batinic-Haberle; Zrinka Rajic; Artak Tovmasyan; Julio S Reboucas; Xiaodong Ye; Kam W Leong; Mark W Dewhirst; Zeljko Vujaskovic; Ludmil Benov; Ivan Spasojevic
Journal:  Free Radic Biol Med       Date:  2011-05-06       Impact factor: 7.376

3.  Mn porphyrin in combination with ascorbate acts as a pro-oxidant and mediates caspase-independent cancer cell death.

Authors:  Myron K Evans; Artak Tovmasyan; Ines Batinic-Haberle; Gayathri R Devi
Journal:  Free Radic Biol Med       Date:  2013-12-12       Impact factor: 7.376

Review 4.  Manganese superoxide dismutase, MnSOD and its mimics.

Authors:  Sumitra Miriyala; Ivan Spasojevic; Artak Tovmasyan; Daniela Salvemini; Zeljko Vujaskovic; Daret St Clair; Ines Batinic-Haberle
Journal:  Biochim Biophys Acta       Date:  2011-12-09

5.  Cytotoxic effects of Mn(III) N-alkylpyridylporphyrins in the presence of cellular reductant, ascorbate.

Authors:  Xiaodong Ye; Diane Fels; Artak Tovmasyan; Katherine M Aird; Casey Dedeugd; Jennifer L Allensworth; Ivan Kos; Won Park; Ivan Spasojevic; Gayathri R Devi; Mark W Dewhirst; Kam W Leong; Ines Batinic-Haberle
Journal:  Free Radic Res       Date:  2011-09-27

6.  Cellular redox modulator, ortho Mn(III) meso-tetrakis(N-n-hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP(5+) in the treatment of brain tumors.

Authors:  Stephen T Keir; Mark W Dewhirst; John P Kirkpatrick; Darell D Bigner; Ines Batinic-Haberle
Journal:  Anticancer Agents Med Chem       Date:  2011-02       Impact factor: 2.505

Review 7.  Simple biological systems for assessing the activity of superoxide dismutase mimics.

Authors:  Artak Tovmasyan; Julio S Reboucas; Ludmil Benov
Journal:  Antioxid Redox Signal       Date:  2013-10-19       Impact factor: 8.401

Review 8.  SOD therapeutics: latest insights into their structure-activity relationships and impact on the cellular redox-based signaling pathways.

Authors:  Ines Batinic-Haberle; Artak Tovmasyan; Emily R H Roberts; Zeljko Vujaskovic; Kam W Leong; Ivan Spasojevic
Journal:  Antioxid Redox Signal       Date:  2013-10-01       Impact factor: 8.401

9.  Manganoporphyrins increase ascorbate-induced cytotoxicity by enhancing H2O2 generation.

Authors:  Malvika Rawal; Samuel R Schroeder; Brett A Wagner; Cameron M Cushing; Jessemae L Welsh; Anna M Button; Juan Du; Zita A Sibenaller; Garry R Buettner; Joseph J Cullen
Journal:  Cancer Res       Date:  2013-06-13       Impact factor: 12.701

10.  Anticancer therapeutic potential of Mn porphyrin/ascorbate system.

Authors:  Artak Tovmasyan; Romulo S Sampaio; Mary-Keara Boss; Jacqueline C Bueno-Janice; Bader H Bader; Milini Thomas; Julio S Reboucas; Michael Orr; Joshua D Chandler; Young-Mi Go; Dean P Jones; Talaignair N Venkatraman; Sinisa Haberle; Natalia Kyui; Christopher D Lascola; Mark W Dewhirst; Ivan Spasojevic; Ludmil Benov; Ines Batinic-Haberle
Journal:  Free Radic Biol Med       Date:  2015-10-20       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.